FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1488279901> ?p ?o ?g. }

• W1488279901 endingPage "12" @default.
• W1488279901 startingPage "2" @default.
• W1488279901 abstract "Pharmacological neuroprotection aims at neutralising some of the effects of the nerve-derived toxic factors, thereby increasing the ability of the spared neurons to cope with stressful conditions. Understanding of the role of extracellular calcium transport across cell membranes in modulating various intracellular signaling processes, including the initiation of the apoptotic cascade, represents part of the rationale for interest in investigating calcium-channel blockers for neuroprotection in such blinding eye diseases as glaucoma and retinitis pigmentosa. Glaucoma is a major cause of worldwide irreversible blindness. Bilateral blindness will be present in 5.9 million people with open-angle glaucoma and 5.3 million people with angle-closure glaucoma in 2020. Currently, glaucoma is recognised as an optic neuropathy and the loss of vision in this eye disease is attributed to degeneration of the axons of the retinal ganglion cells through apoptosis. Retinitis pigmentosa (RP) represents a group of progressive hereditary diseases of the retina that lead to incurable blindness and affect two million people worldwide, RP has been known to be initiated by photoreceptor apoptosis as a final common pathway at the cellular level, irrespective of gene mutations. Apoptosis can thus be considered as a therapeutic target in glaucoma and retinitis pigmentosa. This review focuses on cellular events associated with neurodegeneration due to glaucoma and retinitis pigmentosa, and discusses pharmacological agents believed to have a neuroprotective role in these diseases .It is time to conduct a randomized controlled trial to provide direct evidence of the effectiveness of specific type calcium channel blocker in glaucoma and retinitis pigmentosa. New intervention as pharmacological neuroprotection by calcium channel blockers remains an important strategy to limit the morbidity of these eye diseases representing significant health problem. Keywords: Glaucoma, Retinitis pigmentosa, Apoptosis, Calcium channel blockers, Neuroprotection" @default.
• W1488279901 created "2016-06-24" @default.
• W1488279901 creator A5058472912 @default.
• W1488279901 date "2012-01-01" @default.
• W1488279901 modified "2023-09-24" @default.
• W1488279901 title "Pharmacological Neuroprotection in Blinding Eye Diseases" @default.
• W1488279901 cites W114264706 @default.
• W1488279901 cites W134600271 @default.
• W1488279901 cites W1489656485 @default.
• W1488279901 cites W1529146532 @default.
• W1488279901 cites W1556624435 @default.
• W1488279901 cites W1589546744 @default.
• W1488279901 cites W160990140 @default.
• W1488279901 cites W1726278660 @default.
• W1488279901 cites W1889509997 @default.
• W1488279901 cites W1965185652 @default.
• W1488279901 cites W1970357151 @default.
• W1488279901 cites W1973653580 @default.
• W1488279901 cites W1973751674 @default.
• W1488279901 cites W1975342168 @default.
• W1488279901 cites W1976828978 @default.
• W1488279901 cites W1980429584 @default.
• W1488279901 cites W1981842396 @default.
• W1488279901 cites W1987984585 @default.
• W1488279901 cites W1988232847 @default.
• W1488279901 cites W1990092715 @default.
• W1488279901 cites W1990523450 @default.
• W1488279901 cites W1996037300 @default.
• W1488279901 cites W1997796740 @default.
• W1488279901 cites W2001051543 @default.
• W1488279901 cites W2002758562 @default.
• W1488279901 cites W2011777530 @default.
• W1488279901 cites W2013296679 @default.
• W1488279901 cites W2015963628 @default.
• W1488279901 cites W2016382007 @default.
• W1488279901 cites W2017379135 @default.
• W1488279901 cites W2019111376 @default.
• W1488279901 cites W2021539427 @default.
• W1488279901 cites W2027261270 @default.
• W1488279901 cites W2027354905 @default.
• W1488279901 cites W2033668145 @default.
• W1488279901 cites W2034622757 @default.
• W1488279901 cites W2040269004 @default.
• W1488279901 cites W2041099386 @default.
• W1488279901 cites W2044101213 @default.
• W1488279901 cites W2047748500 @default.
• W1488279901 cites W2049041989 @default.
• W1488279901 cites W2055068342 @default.
• W1488279901 cites W2056886746 @default.
• W1488279901 cites W2057266151 @default.
• W1488279901 cites W2062888354 @default.
• W1488279901 cites W2063043584 @default.
• W1488279901 cites W2068800778 @default.
• W1488279901 cites W2070864125 @default.
• W1488279901 cites W2074668040 @default.
• W1488279901 cites W2074689313 @default.
• W1488279901 cites W2075299947 @default.
• W1488279901 cites W2080258263 @default.
• W1488279901 cites W2086996191 @default.
• W1488279901 cites W2087303190 @default.
• W1488279901 cites W2092178721 @default.
• W1488279901 cites W2093466046 @default.
• W1488279901 cites W2096993232 @default.
• W1488279901 cites W2099151597 @default.
• W1488279901 cites W2108645706 @default.
• W1488279901 cites W2119609658 @default.
• W1488279901 cites W2136984433 @default.
• W1488279901 cites W2141722155 @default.
• W1488279901 cites W2152604912 @default.
• W1488279901 cites W2153137851 @default.
• W1488279901 cites W2153899225 @default.
• W1488279901 cites W2166408526 @default.
• W1488279901 cites W2168157996 @default.
• W1488279901 cites W2184023427 @default.
• W1488279901 cites W2290312602 @default.
• W1488279901 cites W2323204661 @default.
• W1488279901 cites W2331412123 @default.
• W1488279901 cites W2331651028 @default.
• W1488279901 cites W2394847917 @default.
• W1488279901 cites W2399708441 @default.
• W1488279901 cites W2012887262 @default.
• W1488279901 hasPublicationYear "2012" @default.
• W1488279901 type Work @default.
• W1488279901 sameAs 1488279901 @default.
• W1488279901 citedByCount "1" @default.
• W1488279901 countsByYear W14882799012017 @default.
• W1488279901 crossrefType "journal-article" @default.
• W1488279901 hasAuthorship W1488279901A5058472912 @default.
• W1488279901 hasConcept C118487528 @default.
• W1488279901 hasConcept C126322002 @default.
• W1488279901 hasConcept C169760540 @default.
• W1488279901 hasConcept C25498285 @default.
• W1488279901 hasConcept C2776925932 @default.
• W1488279901 hasConcept C2778527774 @default.
• W1488279901 hasConcept C2779134260 @default.
• W1488279901 hasConcept C2780827179 @default.
• W1488279901 hasConcept C2781114197 @default.
• W1488279901 hasConcept C71924100 @default.

• next